- ￥10487.32
- Sigma-Aldrich
- made in USA
- R3501
- 2025年12月10日
12 年金牌会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20°C
- 保质期：
1年
- 英文名：
Rifampicin
- 库存：
100⁺瓶
- 供应商：
上海睿安生物13611631389
- CAS号：
13292-46-1
- 规格：
5g/瓶
Sigma货号R3501现货Rifampicin利福平13611631389上海睿安生物
说明
一般描述:化学结构:大环内酯物
应用:利福平用于治疗结核病和与结核病相关的分枝杆菌感染。 其广泛应用于自身免疫性胆汁淤积性肝病，原发性胆汁性肝硬化(PBC)的止痒剂。 它已被证明会引起肝炎。
生化/生理作用
利福平抑制DNA和蛋白质组装成成熟的病毒颗粒。 它通过与RNA聚合酶的亚基结合抑制RNA合成的起始，从而导致细胞死亡。
作用方式：通过与RNA聚合酶的β-亚基结合抑制RNA合成的起始。
抑制DNA和蛋白质组装成成熟的病毒颗粒。
其他说明:保持容器密闭在干燥通风处。产品对光和湿度敏感。储存在惰性气体中。干燥处保存
同行评审论文
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
M I Prince et al.
Gut, 50(3), 436-439 (2002-02-13)
There is evidence to suggest that rifampicin is an effective second line therapy for controlling pruritus in patients with chronic cholestatic liver disease. It is most widely used as an antipruritic agent in the autoimmune cholestatic liver disease, primary biliary
Potential market for novel tuberculosis diagnostics: worth the investment?
Sandra V Kik et al.
The Journal of infectious diseases, 211 Suppl 2, S58-S66 (2015-03-15)
The potential available market (PAM) for new diagnostics for tuberculosis that meet the specifications of the high-priority target product profiles (TPPs) is currently unknown. We estimated the PAM in 2020 in 4 high-burden countries (South Africa, Brazil, China, and India)
In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene.
Samy Figueiredo et al.
Antimicrobial agents and chemotherapy, 53(6), 2657-2659 (2009-03-25)
Two clonally related Acinetobacter baumannii isolates, A1 and A2, were obtained from the same patient. Isolate A2, selected after an imipenem-containing treatment, showed reduced susceptibility to carbapenems. This resistance pattern was related to insertion of the ISAba1 element upstream of
Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus_aureus in experimental foreign-body infection.
Daniela Baldoni et al.
Antimicrobial agents and chemotherapy, 53(3), 1142-1148 (2008-12-17)
We investigated the activity of linezolid, alone and in combination with rifampin (rifampicin), against a methicillin-resistant Staphylococcus_aureus(MRSA) strain in vitro and in a guinea pig model of foreign-body infection. The MIC, minimal bactericidal concentration (MBC) in logarithmic phase
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Rodney Dawson et al.
Lancet (London, England), 385(9979), 1738-1747 (2015-03-22)
New antituberculosis regimens are urgently needed to shorten tuberculosis treatment. Following on from favourable assessment in a 2 week study, we investigated a novel regimen for efficacy and safety in drug-susceptible and multidrug-resistant (MDR) tuberculosis during the first 8 weeks
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Sigma货号R3501现货Rifampicin利福平13611631389上海睿安生物
说明
一般描述:化学结构:大环内酯物
应用:利福平用于治疗结核病和与结核病相关的分枝杆菌感染。 其广泛应用于自身免疫性胆汁淤积性肝病，原发性胆汁性肝硬化(PBC)的止痒剂。 它已被证明会引起肝炎。
生化/生理作用
利福平抑制DNA和蛋白质组装成成熟的病毒颗粒。 它通过与RNA聚合酶的亚基结合抑制RNA合成的起始，从而导致细胞死亡。
作用方式：通过与RNA聚合酶的β-亚基结合抑制RNA合成的起始。
抑制DNA和蛋白质组装成成熟的病毒颗粒。
其他说明:保持容器密闭在干燥通风处。产品对光和湿度敏感。储存在惰性气体中。干燥处保存
同行评审论文
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.
M I Prince et al.
Gut, 50(3), 436-439 (2002-02-13)
There is evidence to suggest that rifampicin is an effective second line therapy for controlling pruritus in patients with chronic cholestatic liver disease. It is most widely used as an antipruritic agent in the autoimmune cholestatic liver disease, primary biliary
Potential market for novel tuberculosis diagnostics: worth the investment?
Sandra V Kik et al.
The Journal of infectious diseases, 211 Suppl 2, S58-S66 (2015-03-15)
The potential available market (PAM) for new diagnostics for tuberculosis that meet the specifications of the high-priority target product profiles (TPPs) is currently unknown. We estimated the PAM in 2020 in 4 high-burden countries (South Africa, Brazil, China, and India)
In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene.
Samy Figueiredo et al.
Antimicrobial agents and chemotherapy, 53(6), 2657-2659 (2009-03-25)
Two clonally related Acinetobacter baumannii isolates, A1 and A2, were obtained from the same patient. Isolate A2, selected after an imipenem-containing treatment, showed reduced susceptibility to carbapenems. This resistance pattern was related to insertion of the ISAba1 element upstream of
Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus_aureus in experimental foreign-body infection.
Daniela Baldoni et al.
Antimicrobial agents and chemotherapy, 53(3), 1142-1148 (2008-12-17)
We investigated the activity of linezolid, alone and in combination with rifampin (rifampicin), against a methicillin-resistant Staphylococcus_aureus(MRSA) strain in vitro and in a guinea pig model of foreign-body infection. The MIC, minimal bactericidal concentration (MBC) in logarithmic phase
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Rodney Dawson et al.
Lancet (London, England), 385(9979), 1738-1747 (2015-03-22)
New antituberculosis regimens are urgently needed to shorten tuberculosis treatment. Following on from favourable assessment in a 2 week study, we investigated a novel regimen for efficacy and safety in drug-susceptible and multidrug-resistant (MDR) tuberculosis during the first 8 weeks
文献支持
Sigma货号R3501现货Rifampicin利福平13611631389上海睿安生物
￥10487.32
